[1] American Academy of Otolaryngology. Position Statement : Otolaryngologists and the COVID-19 Pandemic. https://www.entnet.org/content/aao-hns-position-statement-otolaryngologists-and-covid-19-pandemic Accessed 7th April 2020.
[2]: Jensen AR, Nellemann HM, Overgaard J. Tumor progression in waiting time for 116 radiotherapy in head and neck cancer. Radiother Oncol. 2007;84(1):5-10. 117 doi:10.1016/j.radonc.2007.04.001
[3]: Wyatt RM, Beddoe AH, Dale RG. The effects of delays in radiotherapy treatment on tumour control. Phys Med Biol. 2003;48:139–55
[4]: Murphy CT, Galloway TJ, Handorf EA, et al. Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol. 2016;34:169–78.
[5]: Coca-Pelaz-A, Takes RP, Hutcheson K et al. Head and Neck Cancer: A review of the impact of treatment delay on outcome. Adv Ther. 2018 Feb;35(2):153-160. doi: 10.1007/s12325-018-0663-7
[6]: Schutte HM, Heutink F, Wellenstein DJ et al. Impact of Time to Diagnosis and Treatment in Head and Neck Cancer: A Systematic review. Otolaryngol Head Neck Surg. 2020 Feb 25:194599820906387. doi: 10.1177/0194599820906387
[7]: DeGraff LH, Platek AJ, Iovoli AJ et al. The effect of time between diagnosis and initiation of treatment on outcomes in patients with head and neck squamous cell carcinoma. Oral Oncol. 2019 Sep;96:148-152. doi: 10.1016/j.oraloncology.2019.07.021.
[8]: COVID-19: Elective Case Triage Guidelines for Surgical Care. https://www.facs.org/covid-19/clinical-guidance/elective-case. Accessed 7th April 2020
[9]: Canadian Association of Head & Neck Surgical Oncology (CAHNSO) guidelines for management of Head & Neck Cancer during the COVID-19 Pandemic. Accessed 7th April 2020.
[10]: Mapping 2019-nCOV. https://systems.jhu.edu/research/public-health/ncov/. Accessed 7th April 2020.
[11]: Covid-19 projections assuming full social distancing through May 2020. https://covid19.healthdata.org/united-states-of-america/texas. Accessed 11th April 2020
[12]: MD Anderson Head and Neck Surgery Treatment Guidelines Consortium. Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during COVID-19. Authorea . April 2020
[13]: Shellenberger TD, Weber RS. Multidisciplinary Team Planning for Patients with Head and Neck Cancer. Oral Maxillofac Surg Clin North Am 2018 Nov;30(4):435-444. doi: 10.1016/j.coms.2018.06.005
[14]: S Lei, Jiang F, Su W et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19. EClinicalMedicine (2020). https://doi.org/10.1016/j.eclinm.2020.100331
[15]: Gabrysz-Forget F, Tabet P, Rahal A, et al. Free versus pedicled flaps for reconstruction of head and neck cancer defects: a systematic review. 2019. J Otolaryngol head Neck Surg. 48(13): doi: 10.1186/s40463-019-0334-y
[16]: Hanasono MM, Friel MT, Klem C, et al. Impact of reconstructive microsurgery in patients with advanced oral cavity cancers. Head Neck 2009;31: 1289–1296.
[17]: Kozin ED, Sethi RK, Herr M et al. Comparison of Perioperative Outcomes between the Supraclavicular Artery Island Flap and Fasciocutaneous Free flap. Otolaryngo Head Neck Surg 2016 Jan;154(1):66-72
[18]: Corbitt C, Skoracki RJ, Yu P, Hanasono MM. Free flap failure in head and neck reconstruction. 2014. Head Neck 36(10):1440-5.
[19]: Kovatch KJ, Hanks JE, Steven JR and CL Stucken. Current practices in microvascular reconstruction in otolaryngology-head and neck surgery. Laryngoscope. 2019. 129:138-145.
[20]: Leiser Yoav, Barak M, Ghantous Y, et al. Indications for elective tracheostomy in reconstructive surgery in patients with oral cancer. 2017. J Craniofac Surg. 28(1): e18-22.
[21]: Tay JK, Khoo MLC and WS Loh. Surgical Considerations for Tracheostomy During the COVID-19 Pandemic. 2020. JAMA Otolaryngol Head Neck Surg. Doi:10.100./jamaoto.2020.0764
[22]: World Health Organization. (‎2020)‎. Laboratory testing for coronavirus disease 2019 (‎COVID-19)‎ in suspected human cases: interim guidance, 2 March 2020. World Health Organization. https://apps.who.int/iris/handle/10665/331329. Accessed 7th April 2020
[23]: Wang W, Xu Y, Gao R et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA 2020 Mar 11. Doi:10.1001/jama.2020.3786
[24]: Chen X, Liu J, Li N et al. Otolaryngology providers must be alert for mild and asymptomatic COVID-19 patients. JAMA Oto. https://www.entnet.org/content/oto-journal-covid-19-accepted-papers
[25]: Workman AD, Welling DB, Carter BS, et al. Endonasal instrumentation and aerosolization risk in the era of COVID-19: simulation, literature review, and proposed mitigation strategies. 2020. Int Forum Allergy Rhinol. Doi: 10.1002/alr.22577.
[26]: Maria SA, Fabiana A, Biglioli F, Giovanni F. Role of management of a head and neck department during the COVID-19 Outbreak in Lombardy. JAMA Oto. https://www.entnet.org/content/oto-journal-covid-19-accepted-papers
[27]: Kligerman MP, Vukkadal N, Tsang R et al. Managing the Head and Neck Cancer Patient with Tracheostomy or Laryngectomy During the COVID-19 Pandemic. Head & Neck. https://authorea.com/inst/20973
[28]: Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: A systematic review. PloS One.2012;7(4)
[29]: Chan JYK, Wong EWY, Lam W. Practical Aspects of Otolaryngologic Clinical Services During the 2019 Novel Coronavirus Epidemic: An Experience in Hong Kong. JAMA Otolaryngology– Head & Neck surgery. 2020. Mar 20. Doi:10.1001/jamaoto.2020.0488
[30]: Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335-337.
[31]: Bersanelli M. Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors. Immunotherapy. 2020 Mar 26
[32]: Sun X, Roudi R, Dai T et al. Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis. BMC Cancer. 2019 Jun 10;19(1):558.
[33]: Mehta P, McAuley DF, Brown M et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034.
[34]: Thomson DJ, Palma D, Guckenberger M et al. Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement. Int J Radiat Oncol Biol Phys. https://www.astro.org/Daily-Practice/COVID-19-Recommendations-and-Information/Journal-Articles
[35]: Rosenthal DI. Consequences of mucositis-induced treatment breaks and dose reductions on head and neck cancer treatment outcomes. J Support Oncol 2007 Oct;5(9 Suppl 4):23-32
[36]: Patel RJ et al. Early Institutional Head and Neck Oncologic and Microvascular Surgery Practice Patterns Across the united States during the SARS-CoV-2 (COVID-19) Pandemic. Authorea . April 2020
[37]: Parsons JT, Mendenhall WM, Stringer SP et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer. 2002;94(11):2967–80
[38]: COVID-19: Recommendations for Management of Elective Surgical Procedures. https://www.facs.org/covid-19/clinical-guidance. Accessed 7th April 2020
[39]: Stay Home, Work Safe Order. https://www.readyharris.org/Stay-Home. Accessed 7th April 2020
[40]: TMB Passes Emergency Rules to Enforce Gov. Abbott’s Executive Order GA-09 http://www.tmb.state.tx.us/dl/27277A3D-2F5E-1395-E868-98D48D432C1A. Accessed 7th April 2020
[41]: Information for Travelers Impacted by Governor Abbott’s Executive Order Mandating 14-Day Quarantine for Travelers Coming into Texas by Air and Road. https://www.dps.texas.gov/COVIDtravel/ Accessed 7th April 2020
[42]: Governor Abbott Issues Executive Order Implementing Essential Services And Activities Protocols. https://gov.texas.gov/news/post/governor-abbott-issues-executive-order-implementing-essential-services-and-activities-protocols. Accessed 7th April 2020
[43]: COVID-19 direct. https://covid-19.direct/county/TX/Harris?graph=cases. Accessed 11th April 2020.